According to the new market research report “Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) – Global Forecast to 2025″ published by MarketsandMarkets™.
Revenue Growth Opportunities and Growth Drivers?
The Global Breast Reconstruction Market size is expected to grow from USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%.
Growth Boosting Factors:
- Rising incidence of breast cancer
- Increasing awareness
- Reimbursements for breast reconstruction
- Growth opportunities in emerging markets
- Development of 3D-printed implants
Browse 138 market data Tables and 29 Figures spread through 136 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593
Recent Developments in Breast Reconstruction Industry:
- In 2019, Polytech Health & Aesthetics received US FDA approval for its textured breast implants (macrotextured and polyurethane-coated implants)
- In 2018, J&J launched CPX4 breast tissue expander
- In 2018, Polytech Health & Aesthetics merged with G&G Biotechnology
Leading Key Players in the Worldwide Industry:
The prominent players operating in this market include Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), Silimed (Brazil), Laboratories Arion (France), Guangzhou Wanhe Plastic Materials Co. Ltd.(China), CEREPLAS (France), HansBiomed (South Korea), PMT Corporation (US), and Shanghai Kangning Medical Device (China)
Johnson & Johnson is one of the leading players in the breast reconstruction market. The company offers a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the market.
Geographical Regions Mapped in Report:
The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America held the largest share of the market, followed by Europe. The rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products in this region are the major factors driving the growth of the breast reconstruction in North America.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593
Market Segmentation in Detailed:
Based on the product, is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019.
Based on the procedure, is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2019. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.
Based on type, Breast Reconstruction Market is segmented into unilateral and bilateral. The unilateral segment accounted for the largest market share in 2019. The increasing incidence of breast cancer and rising awareness are major factors responsible for the dominant share of this segment.